Consolidation in the dialysis industry, patient choice, and local market competition

Clinical Journal of the American Society of Nephrology

Volumn 12, Issue 3, 2017, Pages 536-545

  Erickson, Kevin F ^b   Zheng, Yuanchao ^c   Winkelmayer, Wolfgang C ^a   Ho, Vivian ^a,b   Bhattacharya, Jay ^c   Chertow, Glenn M ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b RICE UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Choice Behavior; Chronic; Dialysis; Economic Analysis; Health policy; Humans; Insurance; Insurance Carriers; Kidney Failure; Medicare; Outpatients; Ownership; Patient choice; Peritoneal dialysis; Registries; Renal dialysis; Renal Insufficiency; United States; United States Renal Data System

Indexed keywords

ARTICLE; COMPETITION; DIALYSIS; END STAGE RENAL DISEASE; HEALTH CARE POLICY; HEALTH INSURANCE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MARKET; CHRONIC KIDNEY FAILURE; DECISION MAKING; ECONOMIC ASPECT; ECONOMICS; FEMALE; HEALTH CARE COST; HEALTH CARE FACILITY; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; OUTPATIENT DEPARTMENT; PATIENT PREFERENCE; RESIDENTIAL CARE; TRENDS;

AMBULATORY CARE FACILITIES; CATCHMENT AREA (HEALTH); CHOICE BEHAVIOR; ECONOMIC COMPETITION; FEMALE; HEALTH CARE SECTOR; HEALTH FACILITY MERGER; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OWNERSHIP; PATIENT PREFERENCE; RENAL DIALYSIS;

EID: 85021704236     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06340616     Document Type: Article

References (40)

1. USRDS: Annual Data Report: Atlasof Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2013
2. Department of Health and Human Services, Center for Medicare and Medicaid Services: Medicare Programs; End-Stage Renal Disease Prospective Payment System; Town Hall Meeting on End- Stage Renal Disease Prospective Payment System; Proposed Rule and Notice, Washington, DC, Department of Health and Human Services, 2009, pp 49922–50102
3. Sullivan JD: The end-stage renal disease industry and exit strategies for nephrologists. Health Care Manag (Frederick) 25: 356– 361, 2006
4. Himmelfarb J, Berns A, Szczech L, Wesson D: Cost, quality, and value: The changing political economy of dialysis care. J AmSoc Nephrol 18: 2021–2027, 2007
5. Hirth RA, Held PJ, Orzol SM, Dor A: Practice patterns, case mix, medicare payment policy, and dialysis facility costs. Health Serv Res 33: 1567–1592, 1999
6. Medicare Payment and Advisory Commission. Report to Congress: Medicare Payment Policy, Washington, DC, Medicare Payment and Advisory Commission, March 2015
7. Johnson DS, Meyer KB, Johnson HK: The 2011 ESRD prospective payment system and the survival of an endangered species: The perspective of a not-for-profit medium-sized dialysis organization. Am J Kidney Dis 57: 553–555, 2011
8. Sedor JR, Watnick S, Patel UD, Cheung A, Harmon W, Himmelfarb J, Hostetter TH, Inrig JK, Mehrotra R, Robinson E, Smedberg PC, Shaffer RN; American Society of Nephrology ESRD Task Force: ASN End-Stage Renal Disease Task Force: Perspective on prospective payments for renal dialysis facilities. J AmSoc Nephrol 21: 1235–1237, 2010
9. Gaynor M, Town R: The Impact of Hospital Consolidation: Update, Princeton, NJ, The Robert Wood Johnson Foundation, 2012
10. Baker LC, Bundorf MK, Royalty AB, Levin Z: Physician practice competition and prices paid by private insurers for office visits. JAMA 312: 1653–1662, 2014
11. Farley DO: Competition under fixed prices: Effects on patient selection and service strategies by hemodialysis providers. Med Care Res Rev 53: 330–349, 1996
12. Hirth RA, Chernew ME, Orzol SM: Ownership, competition, and the adoption of new technologies and cost-saving practices in a fixed-price environment. Inquiry 37: 282–294, 2000
13. Held PJ, Pauly MV: Competition and efficiency in the end stage renal disease program. J Health Econ 2: 95–118, 1983
14. Lee DKK, Chertow GM, Zenios SA: Reexploring differences among for-profit and nonprofit dialysis providers. Health Serv Res 45: 633–646, 2010
15. Federal Trade Commission: FTC Requires Fresenius Medical Care AG to Sell 60 Dialysis Clinics Around the Country as a Condition of Acquiring Liberty Dialysis Holdings, Inc. FTC File No 111-0070, Washington, DC, Federal Trade Commission, 2012. Available online at: https://www.ftc.gov/news-events/press-releases/2012/02/ftc-requires-fresenius-medical-care-ag-sell-60-dialysis-clinics. Accessed on December 28, 2015
16. Federal Trade Commission: FTC Accepts Settlement to Remedy DaVita’s Acquisition of Rival Outpatient Dialysis Clinic Provider Gambro. FTC File No: 051-0051, Washington, DC, Federal Trade Commission, 2005. Available at: https://www.ftc.gov/news-events/press-releases/2005/10/ftc-accepts-settlement-remedy-davitas-acquisition-rival. Accessed on December 28, 2015
17. Federal Trade Commission: Maintaining Competition, FTC Allows Fresenius $3.5 Billion Deal to Buy Rival Dialysis Provider Renal Care Group, Washington, DC, Federal Trade Commission, 2006. Available at: https://www.ftc.gov/news-events/press-releases/2006/03/maintaining-competition-ftc-allows-fresenius-35-billion-deal-buy. Accessed on December 28, 2015
18. WWAMI: Rural-Urban Commuting Area Codes (RUCA), Washington, DC, WWAMI Rural Health Research Center, 2005
19. The Dartmouth Institute for Health Policy and Clinical Practice: Selected Hospital and Physician Capacity Measures. Lebanon, NH, The Trustees of Dartmouth College, 2006
20. Church J, Ware R: Industrial Organization: A Strategic Approach, Madison, WI, Irwin McGraw-Hill, 2000
21. Federal Trade Commission: Horizontal Merger Investigation Data: Fiscal Years 1996–2011, Washington, DC, Federal Trade Commission, 2013, p 34
22. Kessler DP, McClellan MB: Is hospital competition socially wasteful? Q J Econ 115: 577–615, 2000
23. Hemmelgarn BR, Manns BJ, Quan H, Ghali WA: Adapting the Charlson Comorbidity index for use in patients with ESRD. Am J Kidney Dis 42: 125–132, 2003
24. Austin PC: Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 28: 3083–3107, 2009
25. US Department of Justice and the Federal Trade Commission: Horizontal Merger Guidelines, Washington, DC, US Department of Justice and Fair Trade Commission, 2010
26. Lacson E Jr., Rogus J, Teng M, Lazarus JM, Hakim RM: The association of race with erythropoietin dose in patients on long-term hemodialysis. Am J Kidney Dis 52: 1104–1114, 2008
27. United States Government Accountability Office: End-Stage Renal Disease: CMS Should Monitor Access to and Quality of Dialysis Care Promptly after Implementation of New Bundled Payment System, Washington, DC, GAO, 2010, p 72
28. Gawande AA, Blendon R, Brodie M, Benson JM, Levitt L, Hugick L: Does dissatisfaction with health plans stem from having no choices? Health Aff (Millwood) 17: 184–194, 1998
29. Lambrew JM:Choice in Health Care: What Do People Really Want. Issue Brief, New York, The Commonwealth Fund, 2005
30. Employee Benefit Research Institute: Health Confidence Survey: Choice in Health Care, Washington, DC, Employee Benefit Research Institute, 2002
31. Dafny L: Hospital industry consolidation–still more to come? N Engl J Med 370: 198–199, 2014
32. Town RJ, Vogt W: How Has Hospital Consolidation Affected the Price and Quality of Hospital Care? Research Synthesis Report, Princeton, NJ, Robert Wood Johnson Foundation, 2006
33. Gaynor M: What Do We Know about Competition and Quality in Health Care Markets? NBER Working Paper Series, Cambridge, MA, National Bureau of Economic Research, 2006
34. Wang V, Lee S-YD, Patel UD, Maciejewski ML, Ricketts TC: Longitudinal analysis of market factors associated with provision of peritoneal dialysis services. Med Care Res Rev 68: 537–558, 2011
35. US Department of Health and Human Services: Health System Measurement Project: Concentration in the Hospital Market, Washington, DC, US Department of Health and Human Services, 2013
36. Businesswire: Renal Care Group to Acquire National Nephrology Associates in Transaction Valued at $345 Million, New York, NY, Business Wire, 2004
37. PR Newswire: DaVita to Acquire Gambro Healthcare, a Renal Dialysis Services Company, New York, NY, PR Newswire, 2004
38. Businesswire: Fresenius Medical Care to Acquire Renal Care Group, Inc., New York, NY, Business Wire, 2004
39. Ramirez E: Antitrust enforcement in health care–controlling costs, improving quality. N Engl J Med 371: 2245–2247, 2014
40. Sage WM, Hyman DA, Greenberg W: Why competition law matters to health care quality. Health Aff (Millwood) 22: 31–44, 2003